Cargando…
The interaction between the endocannabinoid system and the renin angiotensin system and its potential implication for COVID-19 infection
BACKGROUND: Coronavirus disease 2019 (COVID-19) is spreading fast all around the world with more than fourteen millions of detected infected cases and more than 600.000 deaths by 20th July 2020. While scientist are working to find a vaccine, current epidemiological data shows that the most common co...
Autores principales: | Sainz-Cort, Alberto, Heeroma, Joost H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393810/ https://www.ncbi.nlm.nih.gov/pubmed/32835160 http://dx.doi.org/10.1186/s42238-020-00030-4 |
Ejemplares similares
-
Renin-angiotensin-aldosterone system and kidney interactions in heart
failure
por: Ferreira, João Pedro, et al.
Publicado: (2019) -
Renin-angiotensin system blockers and COVID-19
por: Vidal-Petiot, Emmanuelle, et al.
Publicado: (2021) -
Angiotensin-converting enzyme 2 and new insights into the renin–angiotensin system
por: Lambert, Daniel W., et al.
Publicado: (2008) -
Renin Angiotensin System Inhibition as treatment for Covid-19?
por: Williams, Professor Bryan
Publicado: (2021) -
Commentary to Angiotensin-Converting-Enzyme 2 and Renin–Angiotensin System Inhibitors in COVID-19: An Update
por: Ferri, Claudio, et al.
Publicado: (2021)